Global disagreement over drug policies provides an important opportunity to reconsider the effectiveness of existing counternarcotics policies, address their problematic side effects, and propose evidence-based alternative strategies. Because of the differences in attitudes on drug policy around the world, a substantial revision of existing counternarcotics treaties is unlikely at UNGASS 2016. (See also: Improving global drug policy: Comparative perspectives and UNGASS 2016)
This week both the UN Commission on Narcotic Drugs (CND) in Vienna and the UN General Assembly 3rd Committee in New York discuss new drug control resolutions related to upcoming reviews of global drug policy. The high-level CND review in March 2014 and the Special Session of the General Assembly (UNGASS) on drugs in 2016 provide opportunities to change course and to ensure drug policy fully respects human rights.